SPECIALTYPERSPECTIVE New Medical Technology What Do Doctors Want? Keith S. Naunheim, M.D. Saint Louis University Chair, STS Council on Health Policy and.

Slides:



Advertisements
Similar presentations
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Advertisements

Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
CME 101 The Application Process Sponsored by the Office of Continuing Medical Education.
EMPOWERING PHYSICIANS TO DELIVER THE BEST PATIENT CARE Slides courtesy of: Richard W. Waguespack, MD, FACS President Elect, AAO-HNS, Former CPT Editorial.
Adapted from ISEF webpage Society for Science and the Public “Roles and Responsibilities of students and adults” Roles and Responsibilities of students.
“ Linking Blood Pressure and Cardiovascular Health” Welcome We invite you to explore what a membership in the American Society of Hypertension, Inc. (ASH)
Transforming Clinical Practices Grant Opportunity Sponsored by CMS.
CED in the Private Sector: Lessons in Design and Implementation Steve E. Phurrough, MD, MPA September 29,
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Quality Cancer Data The Vital Role of Cancer Registrars in the Fight against Cancer Saves Lives.
Collaboration Across the Spectrum of Formularies in Saskatchewan: The RQHR Perspective Wm. Semchuk, MSc,PharmD,FCSHP Manager, Pharmacy Practice Regina.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
FDA’s Pharmaceutical Inspectorate Robert Coleman National Expert Drug Investigator Food and Drug Administration.
A REVIEW FOR ALL PRESENTERS OF ASMBS-SPONSORED EDUCATIONAL ACTIVITIES ASMBS CME Policies, Procedures and Guidelines for Presenters.
Long Term Care: Medicare Prescription Drug Coverage in Institutions and Our Communities Larry Kocot Vanessa Duran.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
Health Science/Research Policy Group II. Problem Statement Safety and effectiveness of prescription drugs in a real-world environment are uncertain because.
ACHA Policy Advisory Council March 15, Public Reporting  Jeffrey Bott, MD, MBA President of the Florida Society of Cardiovascular and Thoracic.
ASH SPECIALIST PROGRAM REPORT Thomas D. Giles, MD, President of the ASH Specialist Program Inc.,
Overview Public Reporting Cardiovascular Data Recommendations.
Yesterday, today, and tomorrow
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress James D. Cross, M.D. National Head Medical Policy and Program Administration.
RED RIVER COLLEGE PLAR/RPL IN ACTION! Recognizing Prior Learning.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Practice Management: Tips for a Successful GI Practice James J. Weber, MD President & CEO of Texas Digestive Disease Consultants.
0 IRIS A Qualified Clinical Data Registry Consumer-Purchaser Alliance September 9, 2014.
Drug Submissions: Review Process Agnes V. Klein, MD Biologics and Genetic Therapies Directorate February, 2003 www/hc-sc.gc.ca/hpb-dgps/therapeut.
Planned Emergency Research Exception from Informed Consent Requirements September 2007.
Jointly Sponsored by The Warren Alpert Medical School of Brown University and the New England Regional Chapter of the Society of Adolescent Health and.
Key Compliance Risks in Clinical Trials Kathleen Meriwether Principal, ERNST & YOUNG, LLP Fraud Investigation & Dispute Services.
International Congress and Convention Association International Association Overview Ross Robinson 44 th ICCA Congress & Exhibition, Monday, November 7.
Ethics, Business, Innovation Andreas Loefler Adrian Cosenza Australia.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
1 Electronic Records & Confidentiality (Focus on Research) Lawrence H. Muhlbaier, PhD Assistant Professor Biostatistics & Bioinformatics Duke University.
Supporting Informed Formulary Decision Making: CADTH’s Common Drug Review Denis Bélanger, Director, CADTH New Brunswick Stroke Summit November 27, 2010,
Occupational Health. Occupational Medicine Recognized Specialty Since 1949 Combines Clinical Skills With Toxicology, Epidemiology, Safety, Rehabilitation,
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
Program Co-Development in CME: Where have we been? Where are we going? Workshop Facilitators: Dr. Craig Campbell Dr. Jamie Meuser September 21,
Science to Practice: The ACC Tapestry The Quality Colloquium August 21, 2006 Janet S Wright MD FACC.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Other important considerations for RECs Retha Britz.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
Ethical considerations for Bionic Eyes Dr Kate Fox In conjunction with Dr Frederic Gilbert (UTas)
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress 1 How to Implement a Private Payer Reimbursement Strategy Barbara Grenell.
1 National Forum on Biomedical Imaging in Oncology CMS UPDATE Steve Phurrough MD, MPA Director, Coverage and Analysis Group.
Jointly Sponsored by The Warren Alpert Medical School of Brown University and the New England Regional Chapter of the Society of Adolescent Health and.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Science to Practice: The ACC Tapestry The Quality Colloquium August 21, 2006 Janet S Wright MD FACC.
INTERNATIONAL SCIENCE AND ENGINEERING FAIR Rules and Guidelines 2016.
GCP (GOOD CLINICAL PRACTISE)
Rheumatology Mastery in Ankylosing Spondylitis
Rachel Neubrander, PhD Division of Cardiovascular Devices
The Essentia Institute of Rural Health (EIRH) is
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Adherence to the Labeling
The ABAM Certification and Recertification Examination
Maintenance of Certification
Bozeman Health Clinical Research
Erica Takai, PhD for Andrew Farb, M.D.
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Heart Failure Management
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Membership & Professional Standards Committee Spring 2014
Liver and Intestinal Organ Transplantation Committee Spring 2014
ASMBS CME Policies, Procedures and Guidelines for Presenters
Presentation transcript:

SPECIALTYPERSPECTIVE New Medical Technology What Do Doctors Want? Keith S. Naunheim, M.D. Saint Louis University Chair, STS Council on Health Policy and Relationships

SPECIALTYPERSPECTIVE Medical Devices Doctors want to help patients Devices can help patients Doctors & manufacturers can collaborate to help pts

SPECIALTYPERSPECTIVE What Do We Want? It really depends on who “we” is StatesmanPolitico

SPECIALTYPERSPECTIVE What Do We Want? If “we” means practicing surgeons in the community Specialty organizations may have higher standards The standards required are not overly demanding Evidence of benefit Low risk of harm Patient acceptance Reimbursable

SPECIALTYPERSPECTIVE What Do We Want? If “we” means the physician specialty organizations Patient & societal welfare are primary responsibility The standards can and should be more stringent Proven efficacy - peer reviewed papers Proven safety - peer reviewed papers Economic rationale - cost effective Defined candidates - not off label Effectiveness - real world results

SPECIALTYPERSPECTIVE Potential Collaboration Initial CPT code proposal Initial training and CME Long-term follow-up registry Practice guidelines

SPECIALTYPERSPECTIVE Potential Collaboration Initial CPT code proposal Initial training and CME Long-term follow-up registry Practice guidelines

SPECIALTYPERSPECTIVE Why Enlist Specialty? Anyone can propose a new CPT code Industry Physician Specialty society Why not just use inventors and/or investigators? Lack of objectivityToo close; blind spots Bias is unavoidableAcademic prestige Financial interest CPT/RUC/CMS Avoid conflict of interest

SPECIALTYPERSPECTIVE Why Enlist Specialty? Specialty societies can offer distinct advantages Expertise Medical knowledge CPT / RUC rules and process CMS rules and process Contacts Practitioners AMA officials Governmental officials EducationTraining Newsletters Updates

SPECIALTYPERSPECTIVE Specialty’s Desires CommunicationIntent Timing Lead TimeFixed CPT/RUC cycles Surgeons - volunteers Day jobs InformationDevice Personnel Miscellaneous

SPECIALTYPERSPECTIVE Device Information What does it do? What are the risks of its use? What, if anything, does it replace? What competing technologies are in use? How is it different from competing technologies? Why is it better than competing technologies? Is the CPT code proposal device specific? What CPT category is appropriate - I or III?

SPECIALTYPERSPECTIVE Personnel Information Doctor Who is actually involved in service/procedure? What portion of service involves physician work? Who could serve as physician champion/advisor? Patient What patients should be treated with this device? Who should not be treated with this device? How many pts are estimated to be candidates?

SPECIALTYPERSPECTIVE Miscellaneous Is there supportive peer reviewed US literature? Is there a pre-existing code which may apply? Where will the service be provided (OR, office)? Will the service be provided in the postop period?

SPECIALTYPERSPECTIVE Potential Collaboration Initial CPT code proposal Initial training and CME Long-term follow-up registry Practice guidelines

SPECIALTYPERSPECTIVE Early Training & CME Society of Thoracic Surgeons (STS) has sponsored training of its members for many devices Thoracoscopy EUS and TBUS Endovascular stenting Atrial fibrillation ablation Off pump coronary surgery Stentless aortic prosthesis Mechanical circulatory support Official STS Endorsement Program for industry CME programs which meet strict criteria

SPECIALTYPERSPECTIVE Potential Collaboration Initial CPT code proposal Initial training and CME Long-term follow-up registry Practice guidelines

SPECIALTYPERSPECTIVE Registry Follow-up STS National Adult Cardiac Database Voluntary, audited prospective clinical database Has been in existence for 17 years Captures approximately 80% of all cardiac cases Currently contains over 3,000,000 pt records Includes >250 clinical data points per patient Recognized by CMS, NQF, AQA and Congress Major use to date - in hospital quality improvement

SPECIALTYPERSPECTIVE Potential Collaboration Currently negotiating with CMS and FDA to link our clinical database to the CMS administrative database to allow for long term follow-up of TMR and atrial fibrillation surgery CMS Coverage with evidence development FDAPost market surveillance

SPECIALTYPERSPECTIVE Other Databases STS General Thoracic Surgery Database STS Congenital Heart Surgery Database ACS Nat’l Surgery Quality Improvement Project American College of Cardiology (Interventional)

SPECIALTYPERSPECTIVE Potential Collaboration Initial CPT code proposal Initial training and CME Long-term follow-up registry Practice guidelines

SPECIALTYPERSPECTIVE Practice Guidelines Quality Improvement Programs How should the device be used in practice? Who should be allowed to use the device? Training (MD,RN, PA, ANP) Certification Volume criteria Is use of the device a quality measurement? Ensuring quality would maximize the chance for patient benefit and device success

SPECIALTYPERSPECTIVE What We Don’t Want “Me too” devices - same function at higher cost CPT code proposals specific to a single device CPT proposal with little supportive literature CPT proposal for a code not widely used in US Last minute requests for assistance/support Unrealistic predictions regarding outcome/costs Misleading information regarding safety/risks

SPECIALTYPERSPECTIVE What Do We Want? To be able to collaborate with device makers Development of new devices Submission of CPT/RUC proposals Initial training and CME Short and long-term device follow-up Collaboration between specialty societies and device makers could greatly benefit patients To do this we need full disclosure of information both good and bad regardless of economics

SPECIALTYPERSPECTIVE The Perfect Union?

SPECIALTYPERSPECTIVE

SPECIALTYPERSPECTIVE STS Endorsement Program 1.Content based on best, most updated evidence 2.Program is fair, balanced and non-promotional 3.Content cannot disparage other products 4.Must be germane to the work of STS members 5.Content ultimately directed toward benefit of pt Criteria for Endorsement

SPECIALTYPERSPECTIVE STS Endorsement Program 1. The Workforce on Clinical Education will vet activities and presentations for which STS endorsement is sought 2. STS must approve the objectives and final program 3. The organization seeking endorsement must disclose the background of all speakers, including information regarding their potential conflicts of interest and STS must have an opportunity to provide comment/input 4. A significant percentage of speakers should be STS member cardiothoracic surgeons Stipulations

SPECIALTYPERSPECTIVE STS Endorsement Program 5. If wet labs are to be used for demonstrating new procedures and techniques, STS member surgeons should be involved in the majority of the teaching 6. If speakers have a potential conflict of interest (e.g. honorarium, speaker fees, project PI, grants, etc.), this must be disclosed to the program participants both orally and in meeting materials 7. The program as offered to physicians must be in compliance with the American Medical Association's Council on Ethical and Judicial Affairs ethical opinion of Gifts to Physicians from Industry (Opinion 8.061) 8. All educational programs should include an outcomes component that demonstrates the impact of the educational activity on the clinical practice of participants.

SPECIALTYPERSPECTIVE Specialty’s Reward What does the specialty get out of it? Further scientific advancement Improve patient care and outcome Potential additional work for members Fulfillment of professional responsibility

SPECIALTYPERSPECTIVE Whom to Contact Specialty SocietyBilling and coding staffer Coding committee chair Health policy chair Executive director Society president

SPECIALTYPERSPECTIVE Potential Collaboration STS National Adult Cardiac Database Provide trend analysis toAssess product growth Determine market share ID healthcare device needs Provide STS data as a national referent group in new product development studies Identify geographic regions with potential for clinical trial patient enrollment Provide historical data to design clinical trials that can detect meaningful (clinical and statistical) differences

SPECIALTYPERSPECTIVE Category I CPT Codes This category of CPT codes is based upon the procedure being consistent with contemporary medical practice and - the service/procedure received approval from the Food and Drug Administration (FDA) - many health care professionals perform the service or procedure in multiple locations across the country - the clinical efficacy of the service/procedure has been well established and documented

SPECIALTYPERSPECTIVE Category III Codes Emerging Technology Temporary tracking code for new & emerging technology Data collection Assessment of new services & procedures Substantiate widespread usage Useful for FDA approval process Used for reimbursement negotiations (CMDs, private payers) May not conform to the usual CPT code requirements: - the service/procedure has proven clinical efficacy - FDA approval documented/imminent in a given CPT cycle - performed by healthcare professionals across the country